Effects of Chinese herbal cataplasm Xiaozhang Tie on cirrhotic ascites

• Published in: Journal of ethnopharmacology Vol. 139; no. 2; pp. 343 - 349
• Main Authors: Xing, Feng, Tan, Ye, Yan, Guang-Jun, Zhang, Jian-Jun, Shi, Zhao-Hong, Tan, Shan-Zhong, Feng, Nian-Ping, Liu, Cheng-Hai
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 31.01.2012
• Subjects: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Ascites - diagnosis; Ascites - drug therapy; Ascites - etiology; Cataplasm; Chi-Square Distribution; China; Cirrhotic ascites; Drugs, Chinese Herbal - administration & dosage; Drugs, Chinese Herbal - adverse effects; Drugs, Chinese Herbal - therapeutic use; Female; Humans; Liver Cirrhosis - complications; Male; Middle Aged; Phytotherapy; Placebos; Time Factors; Traditional Chinese medicine; Treatment Outcome; Umbilicus; Xiaozhang Tie; China; SBP; RCT; Cataplasm; ITT; Traditional Chinese medicine; ALT; SD; GCP; Cirrhotic ascites; Alb; TBil; Xiaozhang Tie; TCM
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2011.10.040

Conventional methods of treating cirrhotic ascites are inadequate. We sought to identify a novel, effective approach to relieve the suffering of patients with cirrhotic ascites. To investigate the efficacy of Xiaozhang Tie, a traditional Chinese herbal cataplasm composed of dahuang (Rheum palmatum L.), laifuzi (Raphanus sativus L.), concocted gansui (Euphorbia kansui T.N. Liou ex T.P. Wang), chenxiang [Aquilaria sinensis (Lour.) Gilg], dingxiang (Eugenia caryophyllata Thunb.), bingpian (Borneolum syntheticum) and shexiang (artificial Moschus), as an adjuvant in treating cirrhotic ascites. A multicenter, randomized, placebo-controlled trial was conducted. One hundred patients with cirrhotic ascites were divided into two groups of equal size. The test group took an umbilical compress with Xiaozhang Tie for 30 days while the control group was administered an umbilical compress with placebo, in addition to primary therapy. Efficacy was evaluated according to the criteria including ascites volume, urine 24-h volume, abdominal circumference, body weight, abdominal distention, appetite, flatus and defecation. Ninety-two patients completed the study, 7 were withdrawn and 1 was excluded. The effective rate of grades I and II was 63.3% for the test group (n=49) and 38.0% for the control one (n=50). Both groups showed decreased body weight and abdominal circumference, increased urine volume and improved symptoms after treatment. However, the differences between pre-treatment and post-treatment in body weight, abdominal circumference and urine volume were 8.7±5.8kg, 12.4±8.3cm and 683±644ml respectively in the test group, noticeably higher than those in the control group, which were 5.3±4.6kg, 8.0±6.5cm and 372±697ml, respectively. The ranking orders of the symptoms of the test group were significantly lower than those of the control group after treatment. No severe adverse reactions were seen. Xiaozhang Tie as an adjuvant to primary therapy of cirrhotic ascites is safe and shows a remarkable efficacy on relieving abdominal distention.